Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCloudtag Inc Regulatory News (CTAG)

  • There is currently no data for CTAG

Tranche 2 Notes

19 Dec 2016 14:35

RNS Number : 2648S
CloudTag Inc.
19 December 2016
 

19 December 2016

 

CloudTag Inc.

("CloudTag" or the "Company")

 

Receipt of £0.85 million and Issue of Part of the Tranche 2 Notes

 

CloudTag (CTAG:LN), the company that brings personal monitoring to the wellbeing, fitness and digital health markets, confirms that further to the announcement of 15 December 2016, it has received net proceeds of £0.85 million (taking into account costs of £0.05 million) in respect of the first part of the Tranche 2 Notes and accordingly has now issued £1,000,000 (at nominal value) of the Tranche 2 Notes to L1 Capital Global Opportunities Master Fund.

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. 

 

CloudTag Inc.

Amit Ben-Haim / Tony Reeves

+1 345 949 45 44

contact@cloudtag.com

UK Investor Relations

+44 (0) 20 7052 8469investors@cloudtag.com

Cairn Financial Advisers LLP (Nominated Adviser)

Tony Rawlinson / Jo Turner

+44 (0) 20 7213 0880

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURGGGGUPUPQGCB
Date   Source Headline
27th Mar 20174:06 pmRNSFinal Results
16th Mar 201710:30 amRNSShareholder update
28th Feb 201711:50 amRNSUpdate on Suspension
28th Feb 201711:50 amRNSResignation of Nominated Adviser
24th Feb 20174:18 pmRNSSuspension - Cloudtag Inc.
24th Feb 20172:05 pmRNSSecond Price Monitoring Extn
24th Feb 20172:00 pmRNSPrice Monitoring Extension
24th Feb 20177:00 amRNSFundraise and Notice of Resignation of Nomad
16th Feb 20175:31 pmRNSCorrection: Conversion of £0.1m Loan Notes
16th Feb 20171:28 pmRNSConversion of £0.1 million Loan Notes
15th Feb 20172:02 pmRNSConversion of £0.3 million Loan Notes
2nd Feb 20177:00 amRNSConversion of £0.4 million Loan Notes
25th Jan 20177:00 amRNSChange of Registered Office
17th Jan 20174:31 pmRNSExercise of Warrants - Receipt of Gross Proceeds
17th Jan 20177:00 amRNSConversion of Loan Notes and Exercise of Warrants
4th Jan 20177:00 amRNSConversion of £0.25 million Loan Notes
3rd Jan 201710:13 amRNSFurther re Tranche 2 Notes
3rd Jan 20177:00 amRNSFurther re Tranche 2 Notes
22nd Dec 20163:17 pmRNSClarification in respect of L1 warrant pricing
22nd Dec 20162:48 pmRNSClarification in respect of L1 warrant pricing
21st Dec 20165:47 pmRNSConversion of £0.7 million Loan Notes
19th Dec 20162:35 pmRNSTranche 2 Notes
16th Dec 20167:30 amRNSRestoration - Cloudtag Inc
15th Dec 20165:37 pmRNSUpdate and Restoration of Trading
12th Dec 20161:26 pmRNSResult of EGM
9th Dec 20165:48 pmRNSConversion of £1.15 million Loan Notes
9th Dec 20163:32 pmRNSSuspension - Cloudtag Inc.
7th Dec 20163:05 pmRNSMovement in Share Price
5th Dec 20163:24 pmRNSMovement in Share Price
1st Dec 20162:10 pmRNSHolding(s) in Company
1st Dec 201612:54 pmRNSHolding(s) in Company
28th Nov 20167:00 amRNSAmendment to Funding Agreement
25th Nov 20167:00 amRNSAgreement Signed with US Sales & Marketing Partner
24th Nov 20167:00 amRNSPosting of Circular
23rd Nov 20167:00 amRNSConversion of £600,000 Loan Notes
21st Nov 201610:54 amRNSAppointment of David He
17th Nov 20162:05 pmRNSSecond Price Monitoring Extn
17th Nov 20162:00 pmRNSPrice Monitoring Extension
14th Nov 20163:38 pmRNSConversion of £700,000 Loan Notes
10th Nov 20167:00 amRNSReceipt of Funds and Issue of Notes
8th Nov 20162:05 pmRNSSecond Price Monitoring Extn
8th Nov 20162:00 pmRNSPrice Monitoring Extension
7th Nov 20164:37 pmRNSFundraising and Update
14th Oct 20163:40 pmRNSExercise of Warrants
4th Oct 20169:19 amRNSExercise of Warrants
27th Sep 20161:01 pmRNSFundraise of £550,000 & Exercise of Warrants
27th Sep 20167:00 amRNSProposed Subscription of £550,000
21st Sep 20167:00 amRNSAppointment of Chief Business Development Officer
12th Sep 20167:00 amRNSOperational Update and Placing to Raise £500,000
5th Sep 201611:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.